Literature DB >> 8486953

Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.

X S Lu1, L Bélec, J Pillot.   

Abstract

To study the specific local immune response in vaginal fluids, 19 women infected with human immunodeficiency virus (HIV) type 1 and 23 seronegative controls were selected. Vaginal fluids were tested by ELISA for total IgG, IgA, and IgM levels and for specific IgG, IgA, and IgM antibodies to gp160. Total IgG, IgA, and IgM concentrations were 6.8-, 5.0-, and 2.5-fold higher, respectively, in HIV-1-infected women than in controls, with a positive correlation between IgG and IgA levels. IgG or IgA antibodies or both to gp160 were detected in 12 subjects (63%), whereas no IgM antibodies to gp160 were found. Anti-gp160 IgG strongly predominated. Serum samples were available for 11 women whose total IgG vaginal levels strongly correlated with total IgG in sera. These results suggest that transudation of serumborne antibodies is the main source of gp160-specific antibodies in the vaginal fluid of HIV-1-infected women.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486953     DOI: 10.1093/infdis/167.5.1189

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women.

Authors:  F X Lü
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

Authors:  C J Miller; M B McChesney; X Lü; P J Dailey; C Chutkowski; D Lu; P Brosio; B Roberts; Y Lu
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

Authors:  X Lü; H Kiyono; D Lu; S Kawabata; J Torten; S Srinivasan; P J Dailey; J R McGhee; T Lehner; C J Miller
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

4.  Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.

Authors:  L Bélec; C Tévi-Bénissan; T Dupré; A S Mohamed; T Prazuck; J Gilquin; J M Kanga; J Pillot
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

5.  Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.

Authors:  Xueling Wu; Susan Jackson
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

6.  Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle.

Authors:  F X Lü; Z Ma; T Rourke; S Srinivasan; M McChesney; C J Miller
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Evidence for early local viral replication and local production of antiviral immunity upon mucosal simian-human immunodeficiency virus SHIV(89.6) infection in Macaca nemestrina.

Authors:  Z Ambrose; K Larsen; J Thompson; Y Stevens; E Finn; S L Hu; M L Bosch
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays.

Authors:  L Bélec; D Meillet; M Lévy; A Georges; C Tévi-Bénissan; J Pillot
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

9.  Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse.

Authors:  L Bélec; G Grésenguet; M A Dragon; D Meillet; J Pillot
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination.

Authors:  J P Bouvet; L Bélec; R Pirès; J Pillot
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.